Physician profile
Chase Campbell
NPI 1306106562
$11,538.41
in general payments reported to CMS, 2019-2025
13 companies · $280 in 2025
The $280 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.65 · 2020: $134 · 2021: $1,020 · 2022: $379 · 2023: $77.77 · 2024: $9,622 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $9,130 · Food and Beverage: $850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $9,130.05 |
| Food and Beverage | $849.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $9,465.54 | 2024 | Magnetom Free.Max, Syngo.Via, Artis Icono Biplane |
| Inari Medical, INC. | $1,093.63 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $321.86 | 2019-2025 | Optablate |
| Bard Peripheral Vascular, INC. | $202.76 | 2020-2021 | |
| Ethicon US, LLC | $148.80 | 2025 | Neuwave |
| Medtronic, INC. | $99.32 | 2022-2023 | Concertotm |
| Boston Scientific Corporation | $73.05 | 2020-2022 | |
| Penumbra, INC. | $34.25 | 2024 | Indigo System |
| Abbott Laboratories | $23.67 | 2021 | |
| Terumo Medical Corporation | $23.17 | 2022 | |
| Biosense Webster, INC. | $23.10 | 2021 | |
| Philips North America LLC | $17.98 | 2025 | Intrasight 2 Mobile |
| Trisalus Life Sciences, INC. | $11.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chase Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.